Work

Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis

Year: 2022

Type: article

Study design: Observational Study

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2022.07.005

Authors: Takeya Sugimoto, Daichi Fujimoto, Yuki Sato, Motohiro Tamiya, Takashi Yokoi, Yoshihiko Taniguchi, Aoi Hino, Akito Hata, Junji Uchida, Yasushi Fukuda, Satoshi Hara, Masaki Kanazu, Hirotaka Matsumoto, Masaki Kokubo, Nobuyuki Yamamoto

Institutions: Wakayama Medical University, Kobe City Medical Center General Hospital, Osaka International Cancer Institute, Hyogo Medical University, NHO Kinki Chuo Chest Medical Center, Chiba University, Osaka Prefectural Medical Center, Kurashiki Central Hospital, Itami City Hospital, Toneyama National Hospital, National Hospital Organization, Hyogo Prefectural Amagasaki General Medical Center, Kobe Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4285097482

FWCI: 1.55

Cites: 18

Cited by: 14

Related to: 10